2023 Form 5500 filing — Cosette Pharmaceuticals, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241010101404NAL0033778880001) for Cosette Pharmaceuticals, Inc. 401(K) Plan, reported by Cosette Pharmaceuticals, Inc. under EIN 83-2305806 and plan number 001. It reports 437 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241010101404NAL0033778880001
Filing year
2023
Form type
2
Plan sponsor
Cosette Pharmaceuticals, Inc.
EIN
83-2305806
Plan number
001
Location
South Plainfield, NJ
Participants
437
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$20,320,550
Total liabilities (EOY)
$0
Net assets (EOY)
$20,320,550
Employer contributions
$908,384
Participant contributions
$2,040,997
Total income / additions
$6,543,038
Benefits paid
$2,407,740
Administrative expenses
$40,374
Total expenses
$2,455,928
Net increase / (decrease)
$4,087,110
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Investments InstitutionalRECORDKEEPER$40,374$0

Related Form 5500 pages